Association between the haemoglobin glycation index (HGI) and clinical outcomes in patients with acute decompensated heart failure

References

• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36(Suppl 1):1–16. doi: 10.2337/dc13-S067.
   PubMed Web of Science ®Google Scholar
• Echouffo-Tcheugui JB, Ndumele CE, Zhang S, et al. Diabetes and progression of heart failure. J Am Coll Cardiol. 2022;79(23):2285–2293. doi: 10.1016/j.jacc.2022.03.378.
   PubMed Web of Science ®Google Scholar
• Kristensen SL, Preiss D, Jhund PS, et al. Risk related to pre–diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial. Circ: heart Failure. 2016;9(1):e002560. doi: 10.1161/CIRCHEARTFAILURE.115.002560.
   PubMed Web of Science ®Google Scholar
• Goode KM, John J, Rigby AS, et al. Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus. Heart. 2009;95(11):917–923. doi: 10.1136/hrt.2008.156646.
   PubMed Web of Science ®Google Scholar
• Elder DHJ, Singh JSS, Levin D, et al. Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study: mean HbA1c and mortality in CHF. Eur J Heart Fail. 2016;18(1):94–102. doi: 10.1002/ejhf.455.
   PubMed Web of Science ®Google Scholar
• Eshaghian S, Horwich TB, Fonarow GC. An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J. 2006;151(1):91.e1–91.e6. doi: 10.1016/j.ahj.2005.10.008.
   Web of Science ®Google Scholar
• Wilson DM, Xing D, Cheng J, et al. Persistence of individual variations in glycated hemoglobin. Diabetes Care. 2011;34(6):1315–1317. doi: 10.2337/dc10-1661.
   PubMed Web of Science ®Google Scholar
• Yudkin JS, Forrest RD, Jackson CA, et al. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia. 1990;33(4):208–215. doi: 10.1007/BF00404798.
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Gal RL, Connor CG, et al. Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. Ann Intern Med. 2017;167(2):95–102. doi: 10.7326/M16-2596.
   PubMed Web of Science ®Google Scholar
• Snieder H, Sawtell PA, Ross L, et al. HbA1c levels are genetically determined even in type 1. Diabetes. Diabetes. 2001;50(12):2858–2863. doi: 10.2337/diabetes.50.12.2858.
   PubMed Web of Science ®Google Scholar
• Pani LN, Korenda L, Meigs JB, et al. Effect of aging on A1C levels in individuals without diabetes. Diabetes Care. 2008;31(10):1991–1996. doi: 10.2337/dc08-0577.
   PubMed Web of Science ®Google Scholar
• Cohen RM, Franco RS, Khera PK, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood. 2008;112(10):4284–4291. doi: 10.1182/blood-2008-04-154112.
   PubMed Web of Science ®Google Scholar
• English E, Idris I, Smith G, et al. The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review. Diabetologia. 2015;58(7):1409–1421. doi: 10.1007/s00125-015-3599-3.
   PubMed Web of Science ®Google Scholar
• Hempe JM, Gomez R, McCarter RJ, et al. High and low hemoglobin glycation phenotypes in type 1 diabetes a challenge for interpretation of glycemic control. J Diabetes Complications. 2002;16(5):313–320. doi: 10.1016/s1056-8727(01)00227-6.
   PubMed Web of Science ®Google Scholar
• Østergaard HB, Mandrup-Poulsen T, Berkelmans GFN, et al. Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients. Diabetes Metab. 2019;45(3):254–260. doi: 10.1016/j.diabet.2018.04.006.
   PubMed Web of Science ®Google Scholar
• Rhee E-J, Cho J-H, Kwon H, et al. Association between coronary artery calcification and the hemoglobin glycation index: the kangbuk samsung health study. J Clin Endocrinol Metab. 2017;102(12):4634–4641. doi: 10.1210/jc.2017-01723.
   PubMed Web of Science ®Google Scholar
• Pan Y, Jing J, Wang Y, et al. Association of hemoglobin glycation index with outcomes of acute ischemic stroke in type 2 diabetic patients. Neurol Res. 2018;40(7):573–580. doi: 10.1080/01616412.2018.1453991.
   PubMed Web of Science ®Google Scholar
• Hempe JM, Yang S, Liu S, et al. Standardizing the haemoglobin glycation index. Endocrino Diabet & Metabol. 2021;4(4):e00299. doi: 10.1002/edm2.299.
   PubMedGoogle Scholar
• Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed. 2004;75(1):45–49. doi: 10.1016/j.cmpb.2003.10.004.
   PubMed Web of Science ®Google Scholar
• Preiss D, Zetterstrand S, McMurray JJV, et al. Predictors of development of diabetes in patients with chronic heart failure in the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. Diabetes Care. 2009;32(5):915–920. doi: 10.2337/dc08-1709.
   PubMed Web of Science ®Google Scholar
• Huang R. Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure. Cardiovasc Diabetol. 2022;21(1):88. doi: 10.1186/s12933-022-01507-7.
   Google Scholar
• Hou X, Liu J, Song J, et al. Relationship of hemoglobin A1c with β cell function and insulin resistance in newly diagnosed and drug naive type 2 diabetes patients. J Diabetes Res. 2016;2016:8797316. doi: 10.1155/2016/8797316.
   PubMed Web of Science ®Google Scholar
• Wei N, Zheng H, Nathan DM. Empirically establishing blood glucose targets to achieve HbA1c goals. Diabetes Care. 2014;37(4):1048–1051. doi: 10.2337/dc13-2173.
   PubMed Web of Science ®Google Scholar
• Cohen RM, Franco RS, Smith EP, et al. When HbA1c and blood glucose do not match: how much is determined by race, by genetics, by differences in mean red blood cell age? J Clin Endocrinol Metab. 2019;104(30):707–710. doi: 10.1210/jc.2018-02409.
   Web of Science ®Google Scholar
• Nayak AU, Singh BM, Dunmore SJ. Potential clinical error arising from use of HbA1c in diabetes: effects of the glycation gap. Endocr Rev. 2019;40(4):988–999. doi: 10.1210/er.2018-00284.
   PubMed Web of Science ®Google Scholar
• van Steen SC, Woodward M, Chalmers J, On behalf of the ADVANCE Collaborative Group., et al. Haemoglobin glycation index and risk for diabetes-related complications in the action in diabetes and vascular disease: preterax and diamicron modified release controlled evaluation (ADVANCE) trial. Diabetologia. 2018;61(4):780–789. doi: 10.1007/s00125-017-4539-1.
   PubMed Web of Science ®Google Scholar
• Kim MK, Jeong JS, Kwon H-S, et al. Concordance the hemoglobin glycation index with glycation gap using glycated albumin in patients with type 2 diabetes. J Diabetes Complications. 2017;31(7):1127–1131. doi: 10.1016/j.jdiacomp.2017.04.015.
   PubMed Web of Science ®Google Scholar
• Hempe JM, Liu S, Myers L, et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care. 2015;38(10):e172–e173. doi: 10.2337/dci15-0001.
   PubMed Web of Science ®Google Scholar
• Ahn CH, Min SH, Lee D-H, et al. Hemoglobin glycation index is associated with cardiovascular diseases in people with impaired glucose metabolism. J Clin Endocrinol Metab. 2017;102(8):2905–2913. doi: 10.1210/jc.2017-00191.
   PubMed Web of Science ®Google Scholar
• Klein KR, Franek E, Marso S, et al. Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE. BMJ Open Diab Res Care. 2021;9(2):e002339. doi: 10.1136/bmjdrc-2021-002339.
   PubMed Web of Science ®Google Scholar
• Xu S, Qin Z, Yuan R, et al. The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus. Front Cardiovasc Med. 2022;9:992252. doi: 10.3389/fcvm.2022.992252.
   PubMed Web of Science ®Google Scholar
• Cheng M-D, Tang J-N, Liu Z-Y, et al. Association of hemoglobin glycation index with prognosis of coronary artery disease after percutaneous coronary intervention: a retrospective cohort study. Diab Vasc Dis Res. 2023;20(4):14791641231193306. doi: 10.1177/14791641231193306.
   Web of Science ®Google Scholar
• Hsia DS, Rasouli N, Pittas AG, et al. Implications of the hemoglobin glycation index on the diagnosis of prediabetes and diabetes. J Clin Endocrinol Metab. 2020;105(3):e130–8–e138. doi: 10.1210/clinem/dgaa029.
   Web of Science ®Google Scholar
• Olson DE, Rhee MK, Herrick K, et al. Screening for diabetes and Pre-Diabetes with proposed A1C-Based diagnostic criteria. Diabetes Care. 2010;33(10):2184–2189. doi: 10.2337/dc10-0433.
   PubMed Web of Science ®Google Scholar
• Barry E, Roberts S, Oke J, et al. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ. 2017;356:i6538. doi: 10.1136/bmj.i6538.
   PubMed Web of Science ®Google Scholar
• Lin L, Wang A, He Y, et al. Effects of the hemoglobin glycation index on hyperglycemia diagnosis: results from the REACTION study. Diabetes Res Clin Pract. 2021;180:109039. doi: 10.1016/j.diabres.2021.109039.
   PubMed Web of Science ®Google Scholar